Publications by authors named "Torres-Parejo Ursula"

To explore the effect of time exposure to flat screen electronic devices with LED lighting and the Mediterranean diet on macular pigment optical density (MPOD). In this cross-sectional observational study, the MPOD was measured by heterochromatic flicker photometry in 164 eyes (47 of younger women aged 20-31 and 35 of older women aged 42-70). Exclusion criteria: evidence of macular degeneration and eyes with cataracts.

View Article and Find Full Text PDF

Background: Macular pigment in retina is formed by lutein and zeaxanthin. These carotenoids must be ingested. Fruit, vegetables, and eggs are rich in lutein and zeaxanthin.

View Article and Find Full Text PDF

The aim of this study was to evaluate the biomechanical changes in the cornea after wearing soft contact lenses (CLs) in healthy myopic patients measured with a Corvis ST (CST, Oculus Optikgeräte GmbH, Wetzlar, Germany) analyser. This prospective, cross-sectional, single-centre study was performed on twenty-two Caucasian patients aged between 19 and 24 years (20.64 ± 1.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate how the timing of anakinra administration during hospital admission affects patient outcomes (death or ICU admission) in those with severe COVID-19 pneumonia, and to explore a simplified scoring system for assessing risk.
  • A retrospective analysis was conducted on 312 patients treated with anakinra and corticosteroids, categorizing them based on when they received anakinra relative to their admission; results indicated that early treatment significantly improved recovery rates compared to late treatment.
  • The patient cohort had an average age of 67.4 years, with comorbidities like hypertension, and overall showed elevated inflammatory markers, with a significant portion experiencing improved clinical outcomes within 30 days, though 27.8% unfortunately still
View Article and Find Full Text PDF

Objectives: To compare the 30-day outcome (mortality and/or ICU admission) of patients admitted for moderate-severe SARS-CoV-2 pneumonia treated with dexamethasone after the Recovery study versus those treated with weight-adjusted methylprednisolone.

Methods: Retrospective cohort study of 65 patients with moderate-severe pneumonia who received dexamethasone 6 mg/day (DXM group) versus 80 treated with weight-adjusted methylprednisolone (MTPN group).

Results: 21 (32.

View Article and Find Full Text PDF

Background: Conflicting data exists regarding risk factors associated with Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia (FD). Few studies examine anxiety/depression in relation to GERD phenotypes (Esophagitis/EE, and Non-Erosive Reflux Disease/NERD), FD, and Rome-IV syndromes. Our aim was to evaluate the association between epidemiological factors and comorbidities with GERD phenotypes, FD, and Rome-IV syndromes, as well as their relationship with anxiety/depression.

View Article and Find Full Text PDF

Objectives: To compare the 30-day outcome (mortality and/or ICU admission) of patients admitted for moderate-severe SARS-CoV-2 pneumonia treated with dexamethasone after the Recovery study versus those treated with weight-adjusted methylprednisolone.

Methods: Retrospective cohort study of 65 patients with moderate-severe pneumonia who received dexamethasone 6 mg/day (DXM group) versus 80 treated with weight-adjusted methylprednisolone (MTPN group).

Results: Twenty-one (32.

View Article and Find Full Text PDF

Medical records contain many terms that are difficult to process. Our aim in this study is to allow visual exploration of the information in medical databases where texts present a large number of syntactic variations and abbreviations by using an interface that facilitates content identification, navigation, and information retrieval. We propose the use of multi-term tag clouds as content representation tools and as assistants for browsing and querying tasks.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate the clinical outcomes of different immunosuppressive treatments in patients with severe COVID-19 pneumonia and moderate inflammation.
  • A total of 142 patients were divided into three groups based on treatment: methylprednisolone alone, tocilizumab alone, and a combination of both, with a follow-up period of 60 days.
  • Results indicated that tocilizumab did not improve clinical outcomes and was associated with a higher ICU admission rate and longer hospital stays, suggesting it should be used cautiously and primarily in clinical trials.
View Article and Find Full Text PDF

Objective: To better understand the clinical, functional and analytical variables associated with delirium in emergencies and their evolution in order to obtain an improvement in the therapeutic approach of the elderly patient, thus preventing morbidity and mortality in this type of patient.

Design: This is a prospective descriptive study of acute confusional syndrome in the emergency department. SITE: General University Hospital of Ciudad Real.

View Article and Find Full Text PDF

Aim: To assess clinical outcomes according to the immunosuppressive treatment administered to patients with severe SARS-CoV-2 pneumonia and moderate inflammation.

Methods: A retrospective observational cohort study involving 142 patients with severe COVID-19 pneumonia and moderate inflammation divided into three treatment groups (pulses of methylprednisolone alone [groupI], tocilizumab alone [groupII] and methylprednisolone plus tocilizumab [groupIII]). The aim was to assess intergroups differences in the clinical course with a 60-day follow-up and related analytical factors.

View Article and Find Full Text PDF

Introduction: Little evidence appears to exist for the use of anakinra, a recombinant interleukin-1 receptor antagonist, after non-response to treatment with corticosteroids alone or combined with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammatory state.

Patients And Methods: A retrospective observational cohort study was carried out involving 143 patients with severe COVID-19 pneumonia and moderate hyperinflammation. They received standard therapy along with pulses of methylprednisolone (group 1) or methylprednisolone plus tocilizumab (group 2), with the possibility of receiving anakinra (group 3) according to protocol.

View Article and Find Full Text PDF